Wellington Global Health Care Equity Fund SGD D AcHRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 21.1 | 0.5 | -0.9 | -1.3 | 1.8 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 21/11/2024 | SGD 13.05 | |
Day Change | 0.54% | |
Morningstar Category™ | Other Equity | |
ISIN | IE00BYW5L636 | |
Fund Size (Mil) 21/11/2024 | USD 2146.49 | |
Share Class Size (Mil) 21/11/2024 | SGD 21.59 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 14/03/2024 | 1.98% |
Investment Objective: Wellington Global Health Care Equity Fund SGD D AcH |
The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Rebecca Sykes 30/06/2022 | ||
Inception Date 21/07/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Wellington Global Health Care Equity Fund SGD D AcH | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 8.90 |
UnitedHealth Group Inc | Healthcare | 7.18 |
Novo Nordisk A/S | 5.18 | |
AstraZeneca PLC | Healthcare | 4.53 |
Merck & Co Inc | Healthcare | 4.44 |
Increase Decrease New since last portfolio | ||
Wellington Global Health Care Equity Fund SGD D AcH |